Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intrahepatic Cholangiocarcinoma (ICC)”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290
What this trial is testing

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Federation Francophone de Cancerologie Digestive 49
Testing effectiveness (Phase 2)UnknownNCT04454905
What this trial is testing

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)UnknownNCT06375915
What this trial is testing

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

Who this might be right for
Intrahepatic Cholangiocarcinoma
Francesco De Cobelli 33
Not applicableUnknownNCT02184871
What this trial is testing

Next Generation Sequencing in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
University of Bologna 45
Not applicableStudy completedNCT07479264
What this trial is testing

A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
First Affiliated Hospital, Sun Yat-Sen University 169
Not applicableNot Yet RecruitingNCT07161869
What this trial is testing

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

Who this might be right for
Hilar CholangiocarcinomaIntrahepatic Cholangiocarcinoma (Icc)Cholangiocarcinoma+3 more
Erasmus Medical Center 250
Not applicableStudy completedNCT07153783
What this trial is testing

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 10,333
Large-scale testing (Phase 3)UnknownNCT03940378
What this trial is testing

Treatment of Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
ICC
The First Affiliated Hospital of Zhengzhou University 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Study completedNCT05348811
What this trial is testing

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Who this might be right for
Cholangiocarcinoma
Zhongda Hospital 25
Not applicableStudy completedNCT07224737
What this trial is testing

Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
City of Hope Medical Center 230
Testing effectiveness (Phase 2)Ended earlyNCT06739252
What this trial is testing

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Perihilar Cholangiocarcinoma
Peking University 1
Not applicableLooking for participantsNCT07176962
What this trial is testing

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Who this might be right for
Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)Extrahepatic Cholangiocarcinoma+3 more
Yingbin Liu, MD, PhD, FACS 1,800
Not applicableNot Yet RecruitingNCT06447454
What this trial is testing

Combining Chemoradiotherapy With Sintilimab in First-Line ICC

Who this might be right for
ICC
Shanghai Zhongshan Hospital 19
Testing effectiveness (Phase 2)Looking for participantsNCT06925516
What this trial is testing

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT06777316
What this trial is testing

An FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)CholangiocarcinomaOther Solid Tumors, Adult+9 more
Cogent Biosciences, Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT06859684
What this trial is testing

Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab
West China Hospital 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946849
What this trial is testing

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Shanghai Zhongshan Hospital 76
Testing effectiveness (Phase 2)Looking for participantsNCT06852287
What this trial is testing

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Gall Bladder Cancer
Tianjin Medical University Cancer Institute and Hospital 33
Testing effectiveness (Phase 2)Study completedNCT04526106
What this trial is testing

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

Who this might be right for
FGFR2 AmplificationFGFR2 Gene MutationFGFR2 Gene Fusion/Rearrangement+5 more
Elevar Therapeutics 490
Load More Results